Annual EBITDA
-$29.18 M
+$1.21 M+3.97%
31 December 2023
Summary:
Cytosorbents annual earnings before interest, taxes, depreciation & amortization is currently -$29.18 million, with the most recent change of +$1.21 million (+3.97%) on 31 December 2023. During the last 3 years, it has fallen by -$19.47 million (-200.56%). CTSO annual EBITDA is now -960.26% below its all-time high of $3.39 million, reached on 31 December 2008.CTSO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.32 M
+$1.66 M+55.68%
30 September 2024
Summary:
Cytosorbents quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.32 million, with the most recent change of +$1.66 million (+55.68%) on 30 September 2024. Over the past year, it has increased by +$7.38 million (+84.85%). CTSO quarterly EBITDA is now -123.34% below its all-time high of $5.64 million, reached on 31 December 2008.CTSO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$16.62 M
+$7.38 M+30.75%
30 September 2024
Summary:
Cytosorbents TTM earnings before interest, taxes, depreciation & amortization is currently -$16.62 million, with the most recent change of +$7.38 million (+30.75%) on 30 September 2024. Over the past year, it has increased by +$11.83 million (+41.58%). CTSO TTM EBITDA is now -431.44% below its all-time high of $5.01 million, reached on 31 December 2008.CTSO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.0% | +84.8% | +41.6% |
| 3 y3 years | -200.6% | +74.5% | +6.9% |
| 5 y5 years | -82.6% | +79.6% | +16.4% |
CTSO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -200.6% | +4.0% | at high | +85.3% | at high | +50.0% |
| 5 y | 5 years | -200.6% | +4.0% | -210.7% | +85.3% | -71.2% | +50.0% |
| alltime | all time | -960.3% | +4.0% | -123.3% | +85.3% | -431.4% | +50.0% |
Cytosorbents EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.32 M(-55.7%) | -$16.62 M(-30.7%) |
| June 2024 | - | -$2.97 M(-33.7%) | -$24.00 M(-11.5%) |
| Mar 2024 | - | -$4.48 M(-42.9%) | -$27.13 M(-10.2%) |
| Dec 2023 | -$29.18 M(-4.0%) | -$7.85 M(-9.7%) | -$30.23 M(+6.2%) |
| Sept 2023 | - | -$8.70 M(+42.5%) | -$28.45 M(-0.1%) |
| June 2023 | - | -$6.10 M(-19.5%) | -$28.50 M(-6.4%) |
| Mar 2023 | - | -$7.58 M(+24.7%) | -$30.46 M(+0.2%) |
| Dec 2022 | -$30.39 M(+40.6%) | -$6.08 M(-30.5%) | -$30.39 M(-8.6%) |
| Sept 2022 | - | -$8.74 M(+8.4%) | -$33.26 M(+12.0%) |
| June 2022 | - | -$8.06 M(+7.4%) | -$29.69 M(+12.3%) |
| Mar 2022 | - | -$7.51 M(-16.1%) | -$26.43 M(+15.3%) |
| Dec 2021 | -$21.62 M(+122.6%) | -$8.95 M(+73.1%) | -$22.92 M(+28.4%) |
| Sept 2021 | - | -$5.17 M(+7.7%) | -$17.86 M(+36.2%) |
| June 2021 | - | -$4.80 M(+20.0%) | -$13.11 M(+22.0%) |
| Mar 2021 | - | -$4.00 M(+3.0%) | -$10.75 M(+10.7%) |
| Dec 2020 | -$9.71 M(-48.2%) | -$3.89 M(+816.3%) | -$9.71 M(-6.5%) |
| Sept 2020 | - | -$424.00 K(-82.6%) | -$10.39 M(-36.7%) |
| June 2020 | - | -$2.43 M(-17.9%) | -$16.41 M(-4.4%) |
| Mar 2020 | - | -$2.97 M(-35.0%) | -$17.17 M(-8.4%) |
| Dec 2019 | -$18.74 M(+17.3%) | -$4.56 M(-29.2%) | -$18.74 M(-5.7%) |
| Sept 2019 | - | -$6.44 M(+101.7%) | -$19.87 M(+23.4%) |
| June 2019 | - | -$3.20 M(-29.6%) | -$16.11 M(-9.7%) |
| Mar 2019 | - | -$4.54 M(-20.2%) | -$17.83 M(+9.2%) |
| Dec 2018 | -$15.98 M(+95.6%) | -$5.69 M(+112.4%) | -$16.34 M(+15.4%) |
| Sept 2018 | - | -$2.68 M(-45.5%) | -$14.16 M(+7.1%) |
| June 2018 | - | -$4.92 M(+61.6%) | -$13.22 M(+33.9%) |
| Mar 2018 | - | -$3.04 M(-13.4%) | -$9.87 M(+20.8%) |
| Dec 2017 | -$8.17 M(-30.1%) | -$3.52 M(+101.8%) | -$8.17 M(-15.8%) |
| Sept 2017 | - | -$1.74 M(+10.9%) | -$9.71 M(-2.9%) |
| June 2017 | - | -$1.57 M(+17.1%) | -$10.00 M(-9.7%) |
| Mar 2017 | - | -$1.34 M(-73.5%) | -$11.07 M(-6.1%) |
| Dec 2016 | -$11.69 M(+27.2%) | -$5.05 M(+148.8%) | -$11.79 M(+25.9%) |
| Sept 2016 | - | -$2.03 M(-23.4%) | -$9.37 M(-0.9%) |
| June 2016 | - | -$2.65 M(+28.8%) | -$9.45 M(+5.0%) |
| Mar 2016 | - | -$2.06 M(-21.7%) | -$9.01 M(-2.0%) |
| Dec 2015 | -$9.19 M | -$2.63 M(+24.2%) | -$9.19 M(-2.9%) |
| Sept 2015 | - | -$2.12 M(-4.0%) | -$9.47 M(+7.5%) |
| June 2015 | - | -$2.20 M(-1.7%) | -$8.81 M(+10.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$2.24 M(-22.8%) | -$7.94 M(+16.2%) |
| Dec 2014 | -$6.83 M(+46.9%) | -$2.90 M(+99.0%) | -$6.83 M(+39.0%) |
| Sept 2014 | - | -$1.46 M(+9.1%) | -$4.92 M(+13.8%) |
| June 2014 | - | -$1.34 M(+17.9%) | -$4.32 M(-1.2%) |
| Mar 2014 | - | -$1.13 M(+14.9%) | -$4.38 M(-5.9%) |
| Dec 2013 | -$4.65 M(+35.3%) | -$987.50 K(+14.3%) | -$4.65 M(+4.4%) |
| Sept 2013 | - | -$863.90 K(-37.8%) | -$4.45 M(+6.5%) |
| June 2013 | - | -$1.39 M(-1.3%) | -$4.18 M(+10.3%) |
| Mar 2013 | - | -$1.41 M(+78.2%) | -$3.79 M(+10.2%) |
| Dec 2012 | -$3.44 M(-21.9%) | -$790.40 K(+33.9%) | -$3.44 M(-4.9%) |
| Sept 2012 | - | -$590.50 K(-40.9%) | -$3.61 M(-14.6%) |
| June 2012 | - | -$998.80 K(-5.5%) | -$4.23 M(-2.1%) |
| Mar 2012 | - | -$1.06 M(+9.1%) | -$4.33 M(-1.5%) |
| Dec 2011 | -$4.40 M(+56.7%) | -$968.40 K(-20.0%) | -$4.39 M(+15.0%) |
| Sept 2011 | - | -$1.21 M(+10.9%) | -$3.82 M(+12.8%) |
| June 2011 | - | -$1.09 M(-2.6%) | -$3.39 M(+14.2%) |
| Mar 2011 | - | -$1.12 M(+182.7%) | -$2.96 M(+5.6%) |
| Dec 2010 | -$2.81 M(-190.7%) | -$396.70 K(-48.9%) | -$2.81 M(-190.3%) |
| Sept 2010 | - | -$776.20 K(+15.9%) | $3.11 M(+1.7%) |
| June 2010 | - | -$670.00 K(-30.5%) | $3.06 M(+5.9%) |
| Mar 2010 | - | -$963.40 K(-117.5%) | $2.88 M(-6.8%) |
| Dec 2009 | $3.10 M(-8.8%) | $5.52 M(-766.6%) | $3.10 M(-3.9%) |
| Sept 2009 | - | -$827.60 K(-1.5%) | $3.22 M(+0.5%) |
| June 2009 | - | -$840.60 K(+11.6%) | $3.20 M(-34.4%) |
| Mar 2009 | - | -$753.00 K(-113.3%) | $4.88 M(-2.6%) |
| Dec 2008 | $3.39 M(-217.9%) | $5.64 M(-768.3%) | $5.01 M(-523.0%) |
| Sept 2008 | - | -$844.40 K(-200.9%) | -$1.19 M(+21.1%) |
| June 2008 | - | $837.20 K(-234.9%) | -$978.90 K(-59.0%) |
| Mar 2008 | - | -$620.70 K(+11.3%) | -$2.39 M(-17.1%) |
| Dec 2007 | -$2.88 M(+68.3%) | -$557.70 K(-12.5%) | -$2.88 M(-8.9%) |
| Sept 2007 | - | -$637.70 K(+12.0%) | -$3.16 M(+1.1%) |
| June 2007 | - | -$569.40 K(-48.8%) | -$3.12 M(-0.4%) |
| Mar 2007 | - | -$1.11 M(+32.4%) | -$3.14 M(+54.2%) |
| Dec 2006 | -$1.71 M | -$839.10 K(+38.8%) | -$2.03 M(+69.3%) |
| Sept 2006 | - | -$604.70 K(+4.0%) | -$1.20 M(-10.6%) |
| June 2006 | - | -$581.40 K(+6660.5%) | -$1.34 M(+76.2%) |
| Feb 2006 | - | -$8600.00(+28.4%) | -$762.70 K(+1.1%) |
| Nov 2005 | - | -$6700.00(-99.1%) | -$754.10 K(+0.9%) |
| Aug 2005 | - | -$747.40 K | -$747.40 K |
FAQ
- What is Cytosorbents annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Cytosorbents?
- What is Cytosorbents annual EBITDA year-on-year change?
- What is Cytosorbents quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Cytosorbents?
- What is Cytosorbents quarterly EBITDA year-on-year change?
- What is Cytosorbents TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Cytosorbents?
- What is Cytosorbents TTM EBITDA year-on-year change?
What is Cytosorbents annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CTSO is -$29.18 M
What is the all time high annual EBITDA for Cytosorbents?
Cytosorbents all-time high annual earnings before interest, taxes, depreciation & amortization is $3.39 M
What is Cytosorbents annual EBITDA year-on-year change?
Over the past year, CTSO annual earnings before interest, taxes, depreciation & amortization has changed by +$1.21 M (+3.97%)
What is Cytosorbents quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CTSO is -$1.32 M
What is the all time high quarterly EBITDA for Cytosorbents?
Cytosorbents all-time high quarterly earnings before interest, taxes, depreciation & amortization is $5.64 M
What is Cytosorbents quarterly EBITDA year-on-year change?
Over the past year, CTSO quarterly earnings before interest, taxes, depreciation & amortization has changed by +$7.38 M (+84.85%)
What is Cytosorbents TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CTSO is -$16.62 M
What is the all time high TTM EBITDA for Cytosorbents?
Cytosorbents all-time high TTM earnings before interest, taxes, depreciation & amortization is $5.01 M
What is Cytosorbents TTM EBITDA year-on-year change?
Over the past year, CTSO TTM earnings before interest, taxes, depreciation & amortization has changed by +$11.83 M (+41.58%)